Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.

@article{Filippidis2005ResistinSL,
  title={Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.},
  author={Georgios Filippidis and Vasilios Liakopoulos and Peter R. Mertens and Theodoros S. Kiropoulos and Nikolaos Stakias and Christina Verikouki and Eftichios Patsidis and Georgios N. Koukoulis and Ioannis Stefanidis},
  journal={Blood purification},
  year={2005},
  volume={23 6},
  pages={421-8}
}
BACKGROUND/AIMS Insulin resistance is a well-known phenomenon in uremia. Resistin, a recently discovered insulin inhibitor secreted by adipocytes, is associated with obesity and insulin resistance in mice. Adiponectin, also secreted by adipocytes, is known to reduce insulin resistance in humans. The aim of the present study was to address the hypothesis that changes in resistin or adiponectin serum levels may relate to body composition and to insulin resistance in patients with end-stage renal… CONTINUE READING